Skip to main content

Table 2 Hematological characteristics of all patients stratified by mSIS

From: Prognostic value of a modified systemic inflammation score in breast cancer patients who underwent neoadjuvant chemotherapy

Parameters

 

High risk

Low risk

P

N = 305 (%)

n = 65 (%)

n = 240 (%)

 

Preneoadjuvant Chemotherapy

 NLRa

-

-

-

-

 LMR

   

 < 0.001

   ≤ 2.96

33 (10.8)

18 (27.7)

15 (6.2)

 

   > 2.96

272 (89.2)

47 (72.3)

225 (93.8)

 

 Lymphocyte

   

 < 0.001

   ≤ 1.96

154 (50.5)

52 (80.0)

102 (42.5)

 

   > 1.96

151 (49.5)

13 (20.0)

138 (57.5)

 

 Neutrophil

   

 < 0.001

   ≤ 3.76

152 (49.8)

11 (16.9)

141 (58.8)

 

   > 3.76

153 (50.2)

54 (83.1)

99 (41.2)

 

 Monocyte

   

0.017

   ≤ 0.41

155 (50.8)

24 (36.9)

131 (54.6)

 

   > 0.41

150 (49.2)

41 (63.1)

109 (45.4)

 

 Hemoglobin

   

0.070

   ≤ 135.4

155 (50.8)

40 (61.5)

115 (47.9)

 

   > 135.4

150 (49.2)

25 (38.5)

125 (52.1)

 

 Platelet

   

0.353

   ≤ 242

154 (50.5)

29 (44.6)

125 (52.1)

 

   > 242

151 (49.5)

36 (55.4)

115 (47.9)

 

 Albumina

-

-

-

-

 Globulin

   

0.991

   ≤ 30

157 (51.5)

34 (52.3)

123 (51.2)

 

   > 30

148 (48.5)

31 (47.7)

117 (48.8)

 

 NLR (median [IQR])

1.82 [1.45, 2.46]

2.97 [2.54, 3.51]

1.66 [1.37, 1.98]

 < 0.001

 LMR (median [IQR])

4.95 [3.75, 6.18]

3.36 [2.90, 4.47]

5.22 [4.26, 6.68]

 < 0.001

 Lymphocyte (median [IQR])

1.96 [1.61, 2.46]

1.50 [1.31, 1.87]

2.14 [1.77, 2.63]

 < 0.001

 Neutrophil (median [IQR])

3.77 [2.97, 4.72]

4.83 [4.04, 5.76]

3.55 [2.86, 4.25]

 < 0.001

 Monocyte (median [IQR])

0.41 [0.34, 0.52]

0.46 [0.38, 0.53]

0.40 [0.33, 0.52]

0.030

 Hemoglobin (median [IQR])

135 [129, 142]

134 [126, 141]

136 [130, 142]

0.158

 Platelet (median [IQR])

242 [211, 283]

251 [206, 299]

239 [211, 279]

0.523

 Albumin (median [IQR])

45.0 [43.0, 46.6]

44.0 [42.2, 45.0]

45.0 [43.0, 47.0]

 < 0.001

 Globulin (median [IQR])

30 [28, 33]

30 [28.9, 33.0]

30 [27.8, 33.0]

0.518

Post Neoadjuvant Chemotherapy

 Lymphocyte

   

0.003

   ≤ 1.54

154 (50.5)

44 (67.7)

110 (45.8)

 

   > 1.54

151 (49.5)

21 (32.3)

130 (54.2)

 

 Neutrophil

   

0.023

   ≤ 3.75

153 (50.2)

24 (36.9)

129 (53.8)

 

   > 3.75

152 (49.8)

41 (63.1)

111 (46.2)

 

 Monocyte

   

0.504

   ≤ 0.53

159 (52.1)

31 (47.7)

128 (53.3)

 

   > 0.53

146 (47.9)

34 (52.3)

112 (46.7)

 

 Hemoglobin

   

0.757

   ≤ 117

153 (50.2)

31 (47.7)

122 (50.8)

 

   > 117

152 (49.8)

34 (52.3)

118 (49.2)

 

 Platelet

   

0.251

   ≤ 271

153 (50.2)

28 (43.1)

125 (52.1)

 

   > 271

152 (49.8)

37 (56.9)

115 (47.9)

 

 Albumin

   

0.983

   ≤ 46.3

256 (83.9)

54 (83.1)

202 (84.2)

 

   > 46.3

49 (16.1)

11 (16.9)

38 (15.8)

 

 Globulin

   

0.609

   ≤ 28

158 (51.8)

36 (55.4)

122 (50.8)

 

   > 28

147 (48.2)

29 (44.6)

118 (49.2)

 

 Lymphocyte (median [IQR])

1.54 [1.19, 1.87]

1.24 [1.07, 1.61]

1.60 [1.31, 1.95]

 < 0.001

 Neutrophil (median [IQR])

3.75 [2.81, 4.81]

3.99 [2.95, 5.06]

3.58 [2.78, 4.65]

0.124

 Monocyte (median [IQR])

0.53 [0.42, 0.68]

0.55 [0.45, 0.69]

0.52 [0.42, 0.68]

0.625

 Hemoglobin (median [IQR])

117 [110, 124]

118 [109, 123]

117 [110, 124]

0.912

 Platelet (median [IQR])

271 [230, 335]

288 [235, 338]

269 [229, 332]

0.402

 Albumin (median [IQR])

43.0 [41.0, 45.0]

43.0 [41.0, 45.0]

43.0 [41.0, 45.0]

0.579

 Globulin (median [IQR])

28.0 [25.0, 31.0]

28.0 [25.0, 30.6]

28.0 [25.1, 31.0]

0.620

  1. mSIS Modified systemic inflammation score, NLR Neutrophil to lymphocyte ratio, LMR Lymphocyte to monocyte ratio
  2. apreneoadjuvant chemotherapy NLR and Alb were excluded from the correlation analysis because they are part of the mSIS